Covaxin: Bharat Biotech permitted to start Phase 3 trials of coronavirus vaccine
The coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin, has been cleared for the third phase of clinical trials.
ليست هناك تعليقات:
إرسال تعليق